title: Neurogenic potential of mesenchymal-like stem cells from human amniotic fluid: the influence of extracellular growth factors.
abstract: Amniotic fluids contain human stem cells, among which mesenchymal stem cells could be isolated. These cells have multipotent differentiation ability and no tumorigenic potential after transplantation in mice. These features make them good candidates for in vitro studies and for therapeutic purposes. The aim of this study was to isolate mesenchymal stem cell-like cultures from different amniotic fluids in order to study in vitro their neurogenic potential and assess if this process could be reproducible and standardized. We focused attention on the possible differential effects of soluble growth factors. Immunophenotypical and molecular characterization showed that the 31 amniotic fluid-derived cultures expressed mesenchymal markers as well as some stemness properties. These cells also appeared to be responsive to purines or acetylcholine showing an intracellular calcium increase, also reported for mesenchymal stem cells derived from other sources. Interestingly, in the presence of retinoic acid, these cells assumed a neuronal-like morphology. In addition, functional and molecular analyses revealed that retinoic acid-treated cells showed immature electric functional properties, the expression of neuronal markers and stemness genes. In conclusion, even if further investigations are required, the results presented here contribute to support the finding that amniotic fluid contains cells able to differentiate in vitro towards neural-like lineage in the presence of retinoic acid. The ability of retinoic acid to induce a possible neuronal progenitor culture makes the model useful to study a possible in vivo transplantation of these cells and to contribute to define the protocols for cell therapy.
authors.affiliation: Department of Molecular Pathology and Innovative Therapies-Histology, Polytechnic University of Marche, Ancona, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Orciani
authors.forename: C
authors.initials: C
authors.lastname: Morabito
authors.forename: M
authors.initials: M
authors.lastname: Emanuelli
authors.forename: S
authors.initials: S
authors.lastname: Guarnieri
authors.forename: D
authors.initials: D
authors.lastname: Sartini
authors.forename: S R
authors.initials: SR
authors.lastname: Giannubilo
authors.forename: R
authors.initials: R
authors.lastname: Di Primio
authors.forename: A L
authors.initials: AL
authors.lastname: Tranquilli
authors.forename: M A
authors.initials: MA
authors.lastname: Mariggiò
mesh_terms: D000328:Adult; D000653:Amniotic Fluid / Q000166:cytology* / Q000378:metabolism; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D064987:Cell- and Tissue-Based Therapy / Q000379:methods; D005260:Female; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism*; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000378:metabolism; D051379:Mice; D039902:Multipotent Stem Cells / Q000166:cytology* / Q000378:metabolism; D009474:Neurons / Q000166:cytology / Q000378:metabolism; D011247:Pregnancy; D014212:Tretinoin / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D036341:Intercellular Signaling Peptides and Proteins; D014212:Tretinoin